A Comparison of the Therapeutic Effects of Metformin, Pioglitazone and Vitamin E in Patients with Non-Alcoholic Fatty Liver

A Comparison of the Therapeutic Effects of Metformin, Pioglitazone and Vitamin E in Patients with Non-Alcoholic Fatty Liver

BACKGROUND AND OBJECTIVE: Non-alcoholic Fatty Liver Disease (NAFLD) is specified by changes in fat in the liver, with or without inflammation. The disease is the hepatic manifestation of metabolic syndrome. Since a different medicinal treatment has been introduced, this study was conducted to compar...

Full description

Bibliographic Details
Main Authors:	K Shahebrahimi, Sh Zulnoorian, A Almasi, A Sharifi, AA Keshvarz, N Farshchian
Format:	Article
Language:	English
Published:	Babol University of Medical Sciences 2017-09-01
Series:	Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul
Subjects:	Non-Alcoholic Fatty Liver Disease Metabolic Syndrome Metformin Pioglitazone Vitamin E
Online Access:	http://jbums.org/browse.php?a_code=A-10-3181-1&slc_lang=en&sid=1

Similar Items

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
by: Karoon Shahebrahimi, et al.
Published: (2016-01-01)

Combined pioglitazone–metformin and clomiphene citrate versus metformin and clomiphene citrate in induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome
by: Ghada Abdel Fattah, et al.
Published: (2014-03-01)

Combination of Pioglitazone and Metformin Actions on Liver Lipid Metabolism in Obese Mice
by: Jieying Liu, et al.
Published: (2023-07-01)

Metformin and Pioglitazone Reduce Gene Expression of Inflammatory Factors in Insulin Resistant and Hypertrophied Adipocytes
by: Zahra Malekpour-Dehkordi, et al.
Published: (2020-12-01)

Evaluation of the Clinical use of Metformin or Pioglitazone in Combination with Meloxicam in Patients with Knee Osteoarthritis; using Knee Injury and Osteoarthritis outcome Score
by: Mohammed M. Mohammed, et al.
Published: (2017-02-01)

Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ
by: Mehran Mesgari Abbasi, et al.
Published: (2016-01-01)

A Histomorphological Comparative Effects of Metformin, Pioglitazone, Repaglinide and Acarbose on Polycystic Ovary in Mice
by: fariba noori, et al.
Published: (2020-04-01)

A meta-analysis of randomized clinical trials on the effect of metformin vs. pioglitazone monotherapy on plasma adiponectin levels among patients with diabetes mellitus
by: Roselle Arbas, et al.
Published: (2024-01-01)

Effects of Pioglitazone and Metformin on Insulin Resistance Reduction in Polycystic Ovary Syndrome: A Comparative Study
by: Amir Ziaie, et al.
Published: (2012-03-01)

Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice
by: Dongmei Wang, et al.
Published: (2022-10-01)

Impact of Fixed Combination of Metformin and Pioglitazone on Insulin Resistance of Patients with Type 2 Diabetes: Results of a Randomized Open-Label Study
by: Sun R, et al.
Published: (2023-09-01)

Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients
by: Young Ki Lee, et al.
Published: (2013-12-01)

Comparative Effect of Insulin Sensitizers and Statin on Metabolic Profile and Ultrasonographical Score in Non Alcoholic Fatty Liver Disease
by: Himanshu Rana, et al.
Published: (2016-08-01)

Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats
by: Abbas Bakhteyari, et al.
Published: (2019-07-01)

Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial
by: Han Zhao, et al.
Published: (2024-02-01)

Development of Capillary Zone Electrophoresis Method for the Simultaneous Separation and Quantification of Metformin and Pioglitazone in Dosage Forms; and Comparison with HPLC Method
by: Maymonah K. I. AlThikrallah, et al.
Published: (2023-01-01)

Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial
by: Mondal Aashish, et al.
Published: (2024-02-01)

Effect of Vitamin E and Metformin on Fatty Liver Disease in Obese Children- Randomized Clinical Trial.
by: Kobra Shiasi Arani, et al.
Published: (2014-10-01)

Clomiphene citrate alone, in combination with metformin or in combination with pioglitazone as first line therapy in induction of ovulation in infertile women with polycystic ovary syndrome, a randomized controlled trial
by: Wessam Magdi Abuelghar, et al.
Published: (2013-09-01)

Effect of pioglitazone on nonalcoholic fatty liver disease in morbid obese patients; a randomized controlled trial
by: Masoud Sayadishahraki, et al.
Published: (2023-01-01)

Pioglitazone: A boon we know less about
by: Dilip Gude
Published: (2013-01-01)

Effect of pioglitazone, quercetin and hydroxy citric acid on extracellular matrix components in experimentally induced non-alcoholic steatohepatitis
by: Surapaneni Krishna Mohan, et al.
Published: (2015-08-01)

Determination of Pioglitazone Hydrochloride in Tablets by High-Performance Liquid Chromatography
by: AMR Lotfy Saber
Published: (2008-12-01)

Comparison of efficacy of add-on therapy of vildagliptin versus pioglitazone among Type 2 Diabetes Mellitus patients inadequately controlled on dual therapy of metformin plus sulfonylurea
by: Kirandeep Kaur
Published: (2014-02-01)

Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: A meta-analysis of randomized controlled trials
by: Zeyu Wang, et al.
Published: (2023-03-01)

Pioglitazone: Indian perspective
by: Rishi Shukla, et al.
Published: (2011-01-01)

Omega-3 fatty acid-based self-microemulsifying drug delivery system (SMEDDS) of pioglitazone: Optimization, in vitro and in vivo studies
by: Nasr A. Emad, et al.
Published: (2023-09-01)

Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats
by: Yi Sui, et al.
Published: (2019-11-01)

Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial
by: Fereshte Attaran, et al.
Published: (2023-09-01)

Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism
by: Hongmei Yan, et al.
Published: (2021-01-01)

The role of pioglitazone in the fight against insulin resistance, atherosclerosis, cardiovascular disease, and non-alcoholic fatty liver disease
by: N. A. Petunina, et al.
Published: (2022-12-01)

Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways
by: Tahmina Yasmin, et al.
Published: (2021-12-01)

The association of vitamin D deficiency with non-alcoholic fatty liver disease
by: Metin Küçükazman, et al.
Published: (2014-08-01)

The Eeffect of Metformin Combined with Calcium-Vitamin D3 Against Diet-Induced Nonalcoholic Fatty Liver Disease
by: Sara Shojaei Zarghani, et al.
Published: (2018-03-01)

Pioglitazone use and the risk of bladder cancer
by: Hsin-Wei Kuo, et al.
Published: (2014-02-01)

Potential Therapeutic Strategy in Chronic Obstructive Pulmonary Disease Using Pioglitazone-Augmented Wharton's Jelly-Derived Mesenchymal Stem Cells
by: Jin-Soo Park, Ph.D, et al.
Published: (2019-04-01)

A retrospective study on finding correlation of pioglitazone and incidences of bladder cancer in the Indian population
by: V Balaji, et al.
Published: (2014-01-01)

Formulation and evaluation of bilayer tablet by using melt granulation technique for treatment of diabetes mellitus
by: Dhruvita Patel, et al.
Published: (2012-01-01)

Vitamins and non-alcoholic fatty liver disease: A molecular insight
by: Sana Raza, et al.
Published: (2021-06-01)

Combined therapy with pioglitazone and FGF21 mRNA synergistically ameliorates metabolic disorders in NAFLD rats
by: Xixia Huang, et al.
Published: (2023-04-01)